AI visual psychophysiological analysis shows high sensitivity for depression screening in 98 outpatients
This single-center prospective diagnostic study evaluated an AI visual psychophysiological analysis platform based on head-neck micro-vibration signals for screening depression and anxiety in 98 outpatients. The platform was compared against standard self-report scales (Self-Rating Depression Scale [SDS] and Self-Rating Anxiety Scale [SAS]), with clinical diagnosis as the reference standard.
The AI tool alone demonstrated 95.9% sensitivity for depression-risk screening, which was higher than the SDS sensitivity of 83.6%. When combined with the self-report scales, the AI+SDS model achieved 98.6% sensitivity for depression screening. For anxiety, the AI+SAS model increased recall by 50.0% (to 69.2%) and improved the F1 score by 25.4%. The combined models showed the best overall discrimination and greatest net clinical benefit in this cohort.
Safety and tolerability data were not reported. Key limitations include the single-center design and small sample size of 98 participants, which restricts generalizability. The study did not report long-term outcomes or validation in broader populations.
For practice, this research suggests a tiered 'AI broad screening + scale refinement' workflow could be a translationally promising paradigm for more objective screening. However, the AI tool is not proven for clinical use and does not replace clinical diagnosis. Findings should be interpreted cautiously until replicated in larger, multi-center studies.